Drug Manufacturers - Specialty & Generic | Healthcare
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Market Cap
1089783595008
Current Price
1254.3
52 Week Range
1020.0 - 1421.49
Previous Close
1254.7
Open
1254.7
Sector
Healthcare
Address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, 500034, India
Phone
+91-40490-02900
Website
https://www.drreddys.com
Day Low
1248.0
Day High
1258.0
Dividend Yield
0.62
PE Ratio
18.513655
Earnings Per Share
67.75
Beta
0.386
EBITDA
88840003584
Book Value
400.705
EPS
67.62244
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Gunupati Venkateswara Prasad B.E. | Co-Chairman, MD & Member of Management Council | 64 | 1960 |
Mr. Kallam Satish Reddy B.Tech., M.S. | Chairman of the Board & Member of the Management Council | 57 | 1967 |
Mr. Erez Israeli M.B.A. | CEO & Member of the Management Council | 56 | 1968 |
Mr. Mannam Venkatanarasimham | CFO & Member of the Management Council | 55 | 1969 |
Mr. Krishna K. Venkatesh B.Pharma M.S. | Global Head of Quality and Pharmacovigilance & Member of the Management Council | 51 | 1973 |
Mr. Deepak Sapra M.B.A. | Global Head of Pharmaceutical Services and Active Ingredients & Member of Management Council | 49 | 1975 |
Mr. Motupalli Venkata Ramana M.B.A. | CEO of Branded Markets - India & Emerging Countries and Member of Management Council | 55 | 1969 |
Ms. Archana Bhaskar B.Sc., M.B.A. | EVP, Head of Corporate Communications, Chief Human Resources Officer & Member of Management Council | 57 | 1967 |
Mr. Sanjay Sharma B.Tech. | Executive VP, Global Head of Global Manufacturing & Member of Management Council | 56 | 1968 |
Mr. Patrick Aghanian B.A., M.B.A. | Head of Generics, Europe & Consumer Health and Member of Management Council | 59 | 1965 |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.